Special Reports:

Our HIV reporting of the past decade

< Back to special reports

A large chunk of our reporting focuses on HIV. Since the launch of Bhekisisa in 2013, we’ve covered HIV in-depth — from the impact of the virus on former president Nelson Mandela’s family to the advances in antiretroviral treatment and anti-HIV pills and injections. We’ve also looked at the impact of inequality and discrimination on the spread of HIV, the link between gender-based violence and HIV — and ways to fix it.

HomeArticles New pills, new rules: What's next for ARVs?

[Watch it again] New pills, new rules: What’s next for ARVs?

In this webinar, a panel of world-class experts discussed what South Africa’s updated guidelines for how we use ARVs may look like.

Speaker profiles

Jeremy Nel

Nel is a physician and infectious diseases specialist, and head of infectious diseases at Helen Joseph Hospital and Wits University. He is president of the Infectious Diseases Society of South Africa, and an active member of the Southern African HIV Clinicians Society. Nel has published research in the fields of HIV, tuberculosis, nontuberculous mycobacteria, COVID and cryptococcal meningitis.

Download his PowerPoint presentation.

Thato Chidarikire

Chidarikire is the acting chief director for HIV, Aids and STIs and the director of HIV prevention programmes in the national department of health. She has over 20 years’ of professional experience in academia, research and the public health sector. Chidarikire has served as co-chair for the WHO HIV testing services guidelines development group, and currently chairs various national HIV prevention technical working groups. 

James Nuttall

Nuttall is a paediatrician and paediatric infectious diseases specialist. He is a senior specialist and senior lecturer at the Red Cross War Memorial Children’s Hospital and the department of paediatrics and child health, University of Cape Town. Nuttall is the current president of the Southern African Society for Paediatric Infectious Diseases and the previous chair of the child and adolescent committee of the Southern African HIV Clinicians Society. 

Download his PowerPoint presentation.

Luckyboy Edison Mkhondwane

Mkhondwane is the prevention and treatment literacy training coordinator at the Treatment Action Campaign (TAC). Mkhondwane has been openly living with HIV after being diagnosed in June 2002, which prompted them to become an access to treatment advocate. They have worked as a prevention and treatment literacy trainer, capacity building officer and policy, communications and research coordinator at TAC Gauteng since joining in July 2002. Mkhondwane has a passion for treatment literacy and community education in HIV and TB treatment.

Download their PowerPoint presentation.

This webinar was presented in partnership with the Southern African HIV Clinicians Society, the national department of health and the Treatment Action Campaign.